For most patients in our clinics, the honest answer is neither, yet
Phase 2 trial (N=338, 48 weeks), the 12 mg dose produced 24.2% mean weight loss, with 26% of participants achieving 30% or more body-weight reduction [2]
Compounded semaglutide, compounded tirzepatide, and research-grade peptide stacks sold through online clinics and messaging groups carry unpredictable sterility, potency, and composition
The physiological landscape of Long COVID, ME/CFS, and related dysautonomias is heavily characterized by a profound, unyielding state of oxidative stress
Moreover, the once-weekly dosing option improves patient compliance compared to daily injections or multiple daily oral medications, marking a significant advancement in diabetes treatment